LADIRATUZUMAB
UNII L0BJ40AQ0J

Substance Identification & Data

This profile provides standardized clinical and technical data for Ladiratuzumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) L0BJ40AQ0J.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1629760-28-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
L0BJ40AQ0J
CAS Registry Number
1629760-28-6
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
LADIRATUZUMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C170090
National Cancer Institute reference terminology for clinical and research data.
INN ID
10630
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Ladiratuzumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

LADIRATUZUMAB

Common Names & Synonyms

IMMUNOGLOBULIN G1, ANTI-(HUMAN ZINC TRANSPORTER LIV-1) (HUMAN-MUS MUSCULUS MONOCLONAL HLIV22 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL HLIV22 .KAPPA.-CHAIN, DIMER
LADIRATUZUMAB [INN]

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus